36E79720D0032
Indefinite Delivery Contract
Overview
Government Description
1 LINE ITEM FOR DICLOFENAC NA 1% GEL. AWARDED FOR A BASE YEAR AND 4 1-YEAR OPTION PERIODS. BASE YEAR PERIOD OF PERFORMANCE IS 6/15/2020-6/14/2021.
Awardee
Awarding / Funding Agency
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Multiple Agencies
Vehicle Ceiling
$52,330,802 (0% Used)
Related Opportunity
Analysis Notes
Amendment Since initial award the Ordering Period End Date was extended from 06/14/21 to 06/14/25.
Subcontracting Plan This IDC has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Subcontracting Plan This IDC has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Exelan Pharmaceuticals was awarded
Indefinite Delivery Contract 36E79720D0032 (36E797-20-D-0032)
by
National Acquisition Center
for 1 Line Item For Diclofenac Na 1% Gel. Awarded For A Base Year And 4 1-Year Option Periods. Base Year Period Of Performance Is 6/15/2020-6/14/2021.
in June 2020.
The IDC
has a duration of 5 years and
was awarded
through solicitation Diclofenac Gel 0.01
full & open
with
NAICS 325412 and
PSC 6505
via direct negotiation acquisition procedures with 6 bids received.
The total ceiling is $52,330,802, of which 0% has been used.
Status
(Open)
Modified 4/18/25
Period of Performance
6/14/20
Start Date
6/14/25
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for 36E79720D0032
Transaction History
Modifications to 36E79720D0032
People
Suggested agency contacts for 36E79720D0032
Competition
Number of Bidders
6
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Commercial Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
FYZXNHSQTMG8
Awardee CAGE
6GFC4
Agency Detail
Awarding Office
36E797 NAC PHARMACEUTICALS (36E797)
Funding Office
36E797 NAC PHARMACEUTICALS (36E797)
Created By
michael.olszewski@va.gov
Last Modified By
paul.mueller@va.gov
Approved By
michael.olszewski@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
FL-23
Senators
Marco Rubio
Rick Scott
Rick Scott
Representative
Jared Moskowitz
Last Modified: 4/18/25